{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:07:27Z","timestamp":1793092047484,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lennander Scholarship Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12020-018-1773-3","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T04:07:12Z","timestamp":1538453232000},"page":"384-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-8912","authenticated-orcid":false,"given":"Kosmas","family":"Daskalakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Chatzelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Tsoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nektaria","family":"Papadopoulou-Marketou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios K.","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos V.","family":"Tsolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"key":"1773_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.4065\/mcp.2010.0099","volume":"85","author":"LC Pelosof","year":"2010","unstructured":"L.C. Pelosof, D.E. Gerber, Paraneoplastic syndromes: An approach to diagnosis and treatment. Mayo Clin. Proc. 85, 838\u2013854 (2010)","journal-title":"Mayo Clin. Proc."},{"key":"1773_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/sj.bjc.6603828","volume":"97","author":"G Lorch","year":"2007","unstructured":"G. Lorch, J.L. Gilmore, P.F. Koltz, R.M. Gonterman, R. Laughner, D.A. Lewis, R.L. Konger, K.S. Nadella, R.E. Toribio, T.J. Rosol, J. Foley, Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. Br. J. Cancer 97, 183\u2013193 (2007)","journal-title":"Br. J. Cancer"},{"key":"1773_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1464-410X.2007.07294.x","volume":"101","author":"S Nimalasena","year":"2008","unstructured":"S. Nimalasena, A. Freeman, S. Harland, Paraneoplastic Cushing\u2019s syndrome in prostate cancer: A difficult management problem. BJU Int. 101, 424\u2013427 (2008)","journal-title":"BJU Int."},{"key":"1773_CR4","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1158\/1541-7786.MCR-09-0131","volume":"7","author":"JL Gilmore","year":"2009","unstructured":"J.L. Gilmore, R.M. Gonterman, K. Menon, G. Lorch, D.J. Riese 2nd, A. Robling, J. Foley, Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone. Mol. Cancer Res. 7, 1714\u20131728 (2009)","journal-title":"Mol. Cancer Res."},{"key":"1773_CR5","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1210\/jc.2013-4340","volume":"99","author":"AA Nella","year":"2014","unstructured":"A.A. Nella, M.B. Lodish, E. Fox, F.M. Balis, M.M. Quezado, P.O. Whitcomb, J. Derdak, E. Kebebew, B.C. Widemann, C.A. Stratakis, Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient. J. Clin. Endocrinol. Metab. 99, 3055\u20133059 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1773_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/CMAR.S90169","volume":"8","author":"B Thajudeen","year":"2016","unstructured":"B. Thajudeen, A.K. Salahudeen, Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: Current data and future perspectives. Cancer Manag. Res. 8, 105\u2013114 (2016)","journal-title":"Cancer Manag. Res."},{"key":"1773_CR7","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1677\/ERC-10-0024","volume":"17","author":"G Kaltsas","year":"2010","unstructured":"G. Kaltsas, I.I. Androulakis, W.W. de Herder, A.B. Grossman, Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr. Relat. Cancer 17, R173\u2013R193 (2010)","journal-title":"Endocr. Relat. Cancer"},{"key":"1773_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"I.M. Modlin, K. Oberg, D.C. Chung, R.T. Jensen, W.W. de Herder, R.V. Thakker, M. Caplin, G. Delle Fave, G.A. Kaltsas, E.P. Krenning, S.F. Moss, O. Nilsson, G. Rindi, R. Salazar, P. Ruszniewski, A. Sundin, Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 9, 61\u201372 (2008)","journal-title":"Lancet Oncol."},{"key":"1773_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0889-8588(05)70370-1","volume":"10","author":"JH Keffer","year":"1996","unstructured":"J.H. Keffer, Endocrinopathy and ectopic hormones in malignancy. Hematol. Oncol. Clin. North Am. 10, 811\u2013823 (1996)","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"1773_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s10555-013-9446-4","volume":"32","author":"D Tarin","year":"2013","unstructured":"D. Tarin, Update on clinical and mechanistic aspects of paraneoplastic syndromes. Cancer Metastas. Rev. 32, 707\u2013721 (2013)","journal-title":"Cancer Metastas. Rev."},{"key":"1773_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.critrevonc.2005.04.004","volume":"58","author":"S Spinazze","year":"2006","unstructured":"S. Spinazze, D. Schrijvers, Metabolic emergencies. Crit. Rev. Oncol. Hematol. 58, 79\u201389 (2006)","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1773_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/ENDO:14:2:151","volume":"14","author":"L Bollanti","year":"2001","unstructured":"L. Bollanti, G. Riondino, F. Strollo, Endocrine paraneoplastic syndromes with special reference to the elderly. Endocrine 14, 151\u2013157 (2001)","journal-title":"Endocrine"},{"key":"1773_CR13","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1210\/jc.2014-1315","volume":"99","author":"K Kamp","year":"2014","unstructured":"K. Kamp, R.A. Feelders, R.C. van Adrichem, Y.B. de Rijke, F.H. van Nederveen, D.J. Kwekkeboom, W.W. de Herder, Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Clinical features, diagnosis, management, and follow-up. J. Clin. Endocrinol. Metab. 99, 3060\u20133069 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1773_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/MPA.0b013e3182015f5d","volume":"40","author":"R Schneider","year":"2011","unstructured":"R. Schneider, J. Waldmann, Z. Swaid, A. Ramaswamy, V. Fendrich, D.K. Bartsch, K. Schlosser, Calcitonin-secreting pancreatic endocrine tumors: Systematic analysis of a rare tumor entity. Pancreas 40, 213\u2013221 (2011)","journal-title":"Pancreas"},{"key":"1773_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1530\/EJE-15-0968","volume":"174","author":"K Kamp","year":"2016","unstructured":"K. Kamp, R.A. Alwani, E. Korpershoek, G.J. Franssen, W.W. de Herder, R.A. Feelders, Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors. Eur. J. Endocrinol. 174, 271\u2013280 (2016)","journal-title":"Eur. J. Endocrinol."},{"key":"1773_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New Response Evaluation Criteria in Solid Tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247 (2009)","journal-title":"Eur. J. Cancer"},{"key":"1773_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1210\/jc.2005-1542","volume":"91","author":"AM Isidori","year":"2006","unstructured":"A.M. Isidori, G.A. Kaltsas, C. Pozza, V. Frajese, J. Newell-Price, R.H. Reznek, P.J. Jenkins, J.P. Monson, A.B. Grossman, G.M. Besser, The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management, and long-term follow-up. J. Clin. Endocrinol. Metab. 91, 371\u2013377 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1773_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S1135-57272008000300002","volume":"82","author":"E Elm von","year":"2008","unstructured":"E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, J.P. Vandenbroucke, S. Iniciativa, [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]. Rev. Esp. Salud Publica 82, 251\u2013259 (2008)","journal-title":"Rev. Esp. Salud Publica"},{"key":"1773_CR19","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1530\/ERC-17-0036","volume":"24","author":"GK Dimitriadis","year":"2017","unstructured":"G.K. Dimitriadis, A. Angelousi, M.O. Weickert, H.S. Randeva, G. Kaltsas, A. Grossman, Paraneoplastic endocrine syndromes. Endocr. Relat. Cancer 24, R173\u2013R190 (2017)","journal-title":"Endocr. Relat. Cancer"},{"key":"1773_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1530\/EJE-16-0392","volume":"175","author":"WT Zandee","year":"2016","unstructured":"W.T. Zandee, K. Kamp, R.C. van Adrichem, R.A. Feelders, W.W. de Herder, Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours. Eur. J. Endocrinol. 175, 361\u2013366 (2016)","journal-title":"Eur. J. Endocrinol."},{"key":"1773_CR21","unstructured":"W.D. Travis, E. Brambilla, A.P. Burke, A. Marx, A.G. Nicolson, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, 4th edn. (International Agency for Research on Cancer, Lyon, France, 2015)"},{"key":"1773_CR22","unstructured":"R.V. Lloyd, R.Y. Osamura, G. Kl\u00f6ppel, J. Rosai. WHO Classification of Tumours of Endocrine Organs. (International Agency for Research on Cancer, Lyon, France, 2017)"},{"key":"1773_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","volume":"151","author":"FC Detterbeck","year":"2017","unstructured":"F.C. Detterbeck, D.J. Boffa, A.W. Kim, L.T. Tanoue, The eighth edition lung cancer stage classification. Chest 151, 193\u2013203 (2017)","journal-title":"Chest"},{"key":"1773_CR24","volume-title":"Principles of Cancer Staging. AJCC Cancer Staging Manual","author":"DM Gress","year":"2017","unstructured":"D.M Gress, S.B Edge, F.L Greene, M.K Washington, E.A Asare, J.D Brierley, D.R Byrd, C.C Compton, J. Milburn Jessup, D.P Winchester, M.B Amin, J.E Gershenwald. Principles of Cancer Staging. AJCC Cancer Staging Manual 8th edn. Springer, New York, 2017.","edition":"8th edn."},{"key":"1773_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/1097-0142(19920101)69:1<66::AID-CNCR2820690113>3.0.CO;2-2","volume":"69","author":"MA Dimopoulos","year":"1992","unstructured":"M.A. Dimopoulos, J.F. Fernandez, N.A. Samaan, P.Y. Holoye, R. Vassilopoulou-Sellin, Paraneoplastic Cushing\u2019s syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer. Cancer 69, 66\u201371 (1992)","journal-title":"Cancer"},{"key":"1773_CR26","first-page":"42","volume":"85","author":"NJ Sarlis","year":"2000","unstructured":"N.J. Sarlis, S.J. Chanock, L.K. Nieman, Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J. Clin. Endocrinol. Metab. 85, 42\u201347 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1773_CR27","doi-asserted-by":"publisher","first-page":"R261","DOI":"10.1530\/ERC-16-0538","volume":"24","author":"WT Zandee","year":"2017","unstructured":"W.T. Zandee, K. Kamp, R.C. van Adrichem, R.A. Feelders, W.W. de Herder, Effect of hormone secretory syndromes on neuroendocrine tumor prognosis. Endocr. Relat. Cancer 24, R261\u2013R274 (2017)","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"1773_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/EJE-18-0212","volume":"179","author":"A Osswald","year":"2018","unstructured":"A. Osswald, T. Deutschbein, C.M. Berr, E. Plomer, A. Mickisch, K. Ritzel, J. Schopohl, F. Beuschlein, M. Fassnacht, S. Hahner, M. Reincke, Surviving ectopic Cushing\u2019s syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing\u2019s disease during long-term follow-up. Eur. J. Endocrinol. 179(2), 109\u2013116 (2018)","journal-title":"Eur. J. Endocrinol."},{"key":"1773_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-5-318","volume":"5","author":"K Coners","year":"2011","unstructured":"K. Coners, S.E. Woods, M. Webb, Dual paraneoplastic syndromes in a patient with small cell lung cancer: a case report. J. Med. Case Rep. 5, 318 (2011)","journal-title":"J. Med. Case Rep."},{"key":"1773_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/gut.29.4.537","volume":"29","author":"JC Rambaud","year":"1988","unstructured":"J.C. Rambaud, R. Jian, B. Flourie, M. Hautefeuille, M. Salmeron, F. Thuillier, A. Ruskone, C. Florent, F. Chaoui, J.J. Bernier, Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time. Gut 29, 537\u2013543 (1988)","journal-title":"Gut"},{"key":"1773_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1210\/jc.2015-2436","volume":"101","author":"J Crona","year":"2016","unstructured":"J. Crona, O. Norlen, P. Antonodimitrakis, S. Welin, P. Stalberg, B. Eriksson, Multiple and secondary hormone secretion in patients with metastatic pancreatic neuroendocrine tumours. J. Clin. Endocrinol. Metab. 101, 445\u2013452 (2016)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1773-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T19:20:57Z","timestamp":1569957657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1773-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1773"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1773-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"K.D. has received Lennander Scholarship Fund. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Informed consent"}}]}}